DSIP (Delta Sleep-Inducing Peptide) – Comprehensive Research Overview (2026)

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from rabbit cerebral venous blood in 1974. It is primarily researched for its ability to promote deep (delta-wave) sleep, modulate stress responses, reduce pain, and provide neuroprotection. DSIP has a unique amphiphilic structure that allows it to cross the blood-brain barrier, and it acts on multiple receptor systems including opioid, GABA, and somatostatin pathways.

→ View DSIP (for laboratory research use only)

Chemical Structure and Properties

  • Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
  • Molecular Weight: ≈848 Da
  • Form: Lyophilized powder for subcutaneous or intravenous injection
  • Key Feature: Amphiphilic structure enables blood-brain barrier penetration; acts on multiple CNS receptor systems

Mechanism of Action

  • Promotes delta-wave (slow-wave) sleep via modulation of sleep-regulatory circuits.
  • Modulates opioid receptor activity, contributing to analgesic and stress-reducing effects.
  • Interacts with GABA-A receptors and somatostatin pathways.
  • Reduces cortisol and stress hormone levels.
  • Antioxidant and neuroprotective effects in CNS models.

Clinical Evidence and Research Findings

Early human studies demonstrated sleep-promoting effects and reductions in stress markers. Research has explored DSIP in insomnia, chronic pain, opiate withdrawal, and stress-related disorders. While large-scale RCTs are lacking, the mechanistic data and early human evidence support continued research interest.

→ Interested in researching DSIP? View Product Options

Benefits (Research & Clinical Observations)

  • Promotion of deep, restorative delta-wave sleep
  • Stress adaptation and cortisol reduction
  • Analgesic and pain modulation effects
  • Neuroprotection and antioxidant activity
  • Potential for opiate withdrawal support research

Typical Dosing Protocols (Off-Label / Research)

  • Common protocols: 100–500 μg subcutaneous, 30–60 minutes before sleep
  • Cycles: 5–10 days on, with breaks; or as needed

Safety Profile and Side Effects

DSIP has a favorable safety profile in available studies. Common side effects: mild drowsiness, transient headache. No significant dependence or withdrawal reported.

Summary

DSIP is a naturally occurring sleep-regulatory peptide with multi-system CNS activity, offering research potential in sleep disorders, stress, pain, and neuroprotection. As with all compounds in this library, DSIP is not an approved drug and should only be considered under qualified medical supervision.

For Laboratory Research Use View DSIP →

Disclaimer This overview is strictly educational and based on publicly available scientific literature as of April 2026. It does not constitute medical advice. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.